|Overview : |
A Pharmaceutical pricing policy is a set of written principles or requirements for managing the prices of pharmaceutical products, agreed or adopted by a public institution, a group of purchasing organizations or individual health services.. The importance of attaining affordable access to pharmaceutical products in the global efforts towards universal health coverage has long been recognized. Most recently, the United Nations Sustainable Development Goals (SDGs) has set SDG Target 3.8 as “financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all”. By extension, achieving this SDG is the responsibility of all levels of governments of Member States and the global community.
Currently, there are various options of policy interventions that could be applied for setting, managing or influencing prices of pharmaceutical products that countries can choose from based on their local contexts. Therefore, countries are expected to choose the most suitable pricing intervention(s) that fits its local context before commencing the development of national pricing policy. The Ministry of Health and Social Services (MoHSS) through financial and technical support from the United Nations Development Programme (UNDP) would, therefore, like to recruit a consultant to conduct a situation analysis on pricing strategies and medicines prices in the private and public sector, and makes evidence-based recommendations on the most suitable pricing strategy(s) for Namibia.